table of content
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Point of Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Point of Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Point of Care Overall Market Size
2.1 Global Molecular Diagnostics in Point of Care Market Size: 2022 VS 2030
2.2 Global Molecular Diagnostics in Point of Care Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Point of Care Players in Global Market
3.2 Top Global Molecular Diagnostics in Point of Care Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Point of Care Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Point of Care Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics in Point of Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Point of Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Diagnostics in Point of Care Market Size Markets, 2022 & 2030
4.1.2 Polymerase Chain Reaction
4.1.3 In Situ Hybridization
4.1.4 Gene Chips
4.1.5 Next Generation Sequencing
4.2 By Type - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2023-2030
4.2.3 By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Independent Clinical Laboratories
5.2 By Application - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2023-2030
5.2.3 By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2030
6.2 By Region - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2023-2030
6.2.3 By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.3.2 US Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.3.3 Canada Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.3.4 Mexico Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.4.2 Germany Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.3 France Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.4 U.K. Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.5 Italy Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.6 Russia Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.7 Nordic Countries Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.8 Benelux Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.5.2 China Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.3 Japan Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.4 South Korea Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.5 Southeast Asia Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.6 India Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.6.2 Brazil Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.6.3 Argentina Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.7.2 Turkey Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7.3 Israel Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7.4 Saudi Arabia Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7.5 UAE Molecular Diagnostics in Point of Care Market Size, 2018-2030
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Point of Care Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Corporate Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.2.4 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.2.5 Accelerate Diagnostics Key News
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Corporate Summary
7.3.2 Ador Diagnostics Business Overview
7.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.3.4 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.3.5 Ador Diagnostics Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Major Product Offerings
7.4.4 Beckman Coulter Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.4.5 Beckman Coulter Key News
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Corporate Summary
7.5.2 Becton, Dickinson and Company Business Overview
7.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Major Product Offerings
7.5.4 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.5.5 Becton, Dickinson and Company Key News
7.6 Binx Health
7.6.1 Binx Health Corporate Summary
7.6.2 Binx Health Business Overview
7.6.3 Binx Health Molecular Diagnostics in Point of Care Major Product Offerings
7.6.4 Binx Health Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.6.5 Binx Health Key News
7.7 Biocartis
7.7.1 Biocartis Corporate Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Molecular Diagnostics in Point of Care Major Product Offerings
7.7.4 Biocartis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.7.5 Biocartis Key News
7.8 bioM?rieux
7.8.1 bioM?rieux Corporate Summary
7.8.2 bioM?rieux Business Overview
7.8.3 bioM?rieux Molecular Diagnostics in Point of Care Major Product Offerings
7.8.4 bioM?rieux Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.8.5 bioM?rieux Key News
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Major Product Offerings
7.9.4 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News
7.10 Bosch Healthcare Solutions
7.10.1 Bosch Healthcare Solutions Corporate Summary
7.10.2 Bosch Healthcare Solutions Business Overview
7.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Major Product Offerings
7.10.4 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.10.5 Bosch Healthcare Solutions Key News
7.11 Curetis
7.11.1 Curetis Corporate Summary
7.11.2 Curetis Business Overview
7.11.3 Curetis Molecular Diagnostics in Point of Care Major Product Offerings
7.11.4 Curetis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.11.5 Curetis Key News
7.12 Eurofins Scientific
7.12.1 Eurofins Scientific Corporate Summary
7.12.2 Eurofins Scientific Business Overview
7.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.12.4 Eurofins Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.12.5 Eurofins Scientific Key News
7.13 Genetic Signatures
7.13.1 Genetic Signatures Corporate Summary
7.13.2 Genetic Signatures Business Overview
7.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Major Product Offerings
7.13.4 Genetic Signatures Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.13.5 Genetic Signatures Key News
7.14 Grifols
7.14.1 Grifols Corporate Summary
7.14.2 Grifols Business Overview
7.14.3 Grifols Molecular Diagnostics in Point of Care Major Product Offerings
7.14.4 Grifols Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.14.5 Grifols Key News
7.15 Hibergene Diagnostics
7.15.1 Hibergene Diagnostics Corporate Summary
7.15.2 Hibergene Diagnostics Business Overview
7.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.15.4 Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.15.5 Hibergene Diagnostics Key News
7.16 Lumos Diagnostics
7.16.1 Lumos Diagnostics Corporate Summary
7.16.2 Lumos Diagnostics Business Overview
7.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.16.4 Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.16.5 Lumos Diagnostics Key News
7.17 Roche
7.17.1 Roche Corporate Summary
7.17.2 Roche Business Overview
7.17.3 Roche Molecular Diagnostics in Point of Care Major Product Offerings
7.17.4 Roche Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.17.5 Roche Key News
7.18 Siemens
7.18.1 Siemens Corporate Summary
7.18.2 Siemens Business Overview
7.18.3 Siemens Molecular Diagnostics in Point of Care Major Product Offerings
7.18.4 Siemens Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.18.5 Siemens Key News
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Corporate Summary
7.19.2 Thermo Fisher Scientific Business Overview
7.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.19.4 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.19.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
